BrainStorm Cell Therapeutics Inc (BCLI)

[Fmello]

At 26:07, Lindborg mentions,

"...that we intend to file our data. This was a phase 3 trial. We believe that we have uncovered very important insights which will be summarized to the FDA in a new biologics license application. And it is our hope that this will be substantial evidence and that we can conduct a trial that will bring more information in the context of an approved therapy."

This presentation was on October 7th. Does that mean that Brainstorm has not submitted the BLA yet to the FDA or is she referring to a different BLA for something else?